title: [The challenge to treat hypertensive patients with type 2 diabetes].
abstract: A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications.
  Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000150:complications / Q000188:drug therapy*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000517:prevention & control; D007190:Indapamide / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors
chemical_list: D000959:Antihypertensive Agents; D004232:Diuretics; D007190:Indapamide
vernacular_title: Le défi du traitement de l'hypertension chez les diabétiques de type 2.